Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas

[1]  J. Cowell,et al.  Ponatinib suppresses the development of myeloid and lymphoid malignancies associated with FGFR1 abnormalities , 2012, Leukemia.

[2]  David T. W. Jones,et al.  Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. , 2012, Cancer cell.

[3]  T. Pietsch,et al.  Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology. , 2012, Neuro-oncology.

[4]  D. Brat,et al.  Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma , 2012, Science.

[5]  Pinjun Wan,et al.  Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome , 2012, Genes, chromosomes & cancer.

[6]  Matthew B. Callaway,et al.  MuSiC: Identifying mutational significance in cancer genomes , 2012, Genome research.

[7]  J. Utikal,et al.  Improved survival with MEK inhibition in BRAF-mutated melanoma. , 2012, The New England journal of medicine.

[8]  Dirk Schadendorf,et al.  Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group , 2012 .

[9]  Li Ding,et al.  The Pediatric Cancer Genome Project , 2012, Nature Genetics.

[10]  C. Hawkins,et al.  Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  David T. W. Jones,et al.  Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma , 2012, Nature.

[12]  Li Ding,et al.  Somatic Histone H3 Alterations in Paediatric Diffuse Intrinsic Pontine Gliomas and Non-Brainstem Glioblastomas , 2012, Nature Genetics.

[13]  Kiran C. Bobba,et al.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.

[14]  Fausto J. Rodriguez,et al.  BRAF Alterations in Primary Glial and Glioneuronal Neoplasms of the Central Nervous System With Identification of 2 Novel KIAA1549: BRAF Fusion Variants , 2012, Journal of neuropathology and experimental neurology.

[15]  Wei Wu,et al.  Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers , 2012, The Journal of pathology.

[16]  Matthew W. Wilson,et al.  A Novel Retinoblastoma Therapy from Genomic and Epigenetic Analyses , 2011, Nature.

[17]  Yuchen Jiao,et al.  Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma , 2011, Science.

[18]  Michael C. Rusch,et al.  CREST maps somatic structural variation in cancer genomes with base-pair resolution , 2011, Nature Methods.

[19]  D. Ellison,et al.  Nonredundant functions for Akt isoforms in astrocyte growth and gliomagenesis in an orthotopic transplantation model. , 2011, Cancer research.

[20]  J. Wisoff,et al.  Primary Neurosurgery for Pediatric Low-Grade Gliomas: A Prospective Multi-Institutional Study From the Children's Oncology Group , 2011, Neurosurgery.

[21]  Süleyman Cenk Sahinalp,et al.  deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data , 2011, PLoS Comput. Biol..

[22]  Roger E. Taylor,et al.  Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  A. Iafrate,et al.  BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications , 2011, PloS one.

[24]  P. Kleihues,et al.  Genetic profile of astrocytic and oligodendroglial gliomas , 2011, Brain Tumor Pathology.

[25]  David T. W. Jones,et al.  Oncogenic FAM131B–BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma , 2011, Acta Neuropathologica.

[26]  Kenneth H. Buetow,et al.  Bioinformatics Applications Note Sequence Analysis Bambino: a Variant Detector and Alignment Viewer for Next-generation Sequencing Data in the Sam/bam Format , 2022 .

[27]  Kenneth H. Buetow,et al.  CREBBP mutations in relapsed acute lymphoblastic leukaemia , 2011, Nature.

[28]  S. Mulholland,et al.  Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts , 2011, Acta Neuropathologica.

[29]  T. Merchant,et al.  Survival and long-term health and cognitive outcomes after low-grade glioma. , 2011, Neuro-oncology.

[30]  Kirsten Schmieder,et al.  Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma , 2011, Acta Neuropathologica.

[31]  N. Carter,et al.  Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.

[32]  A. von Deimling,et al.  The Next Generation of Glioma Biomarkers: MGMT Methylation, BRAF Fusions and IDH1 Mutations , 2011, Brain pathology.

[33]  C. Mullighan.  Single nucleotide polymorphism microarray analysis of genetic alterations in cancer. , 2011, Methods in molecular biology.

[34]  Jo-Fen Liu,et al.  A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). , 2010, Neuro-oncology.

[35]  S. Shurtleff,et al.  MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomas , 2010, Acta Neuropathologica.

[36]  M. Katoh.  Genetic alterations of FGF receptors: an emerging field in clinical cancer diagnostics and therapeutics , 2010, Expert review of anticancer therapy.

[37]  G. Reifenberger,et al.  Molecular diagnostics of gliomas: state of the art , 2010, Acta Neuropathologica.

[38]  A. Ashworth,et al.  FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer. , 2010, Cancer research.

[39]  N. Turner,et al.  Fibroblast growth factor signalling: from development to cancer , 2010, Nature Reviews Cancer.

[40]  T. Forshew,et al.  MAPK pathway activation and the origins of pediatric low‐grade astrocytomas , 2009, Journal of cellular physiology.

[41]  D. Ellison,et al.  A multivariate analysis of factors determining tumor progression in childhood low-grade glioma : a population-based cohort study ( CCLG CNS 9702 ) , 2010 .

[42]  鮫島 浩,et al.  Population-based study からみた神経予後不良因子の検討 , 2009 .

[43]  A. Gajjar,et al.  Outcome and prognostic features in pediatric gliomas , 2009, Cancer.

[44]  R. McLendon,et al.  IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.

[45]  J. Birch,et al.  Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England. , 2009, Neuro-oncology.

[46]  T. Merchant,et al.  Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  T. Shaikh,et al.  Duplication of 7q34 in Pediatric Low‐Grade Astrocytomas Detected by High‐Density Single‐Nucleotide Polymorphism‐Based Genotype Arrays Results in a Novel BRAF Fusion Gene , 2009, Brain pathology.

[48]  Hendrik Witt,et al.  Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma , 2009, Acta Neuropathologica.

[49]  Jing Ma,et al.  Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas , 2009, The Journal of pathology.

[50]  D. Pearson,et al.  Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma , 2009, Oncogene.

[51]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[52]  David T. W. Jones,et al.  Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. , 2008, Cancer research.

[53]  D. Busam,et al.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.

[54]  M. Repka,et al.  Outcome analysis of childhood low‐grade astrocytomas , 2008, Pediatric blood & cancer.

[55]  G. Reifenberger,et al.  BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. , 2008, The Journal of clinical investigation.

[56]  T. Golub,et al.  Modeling genomic diversity and tumor dependency in malignant melanoma. , 2008, Cancer research.

[57]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[58]  P. Kleihues,et al.  Genetic pathways to primary and secondary glioblastoma. , 2007, The American journal of pathology.

[59]  D. Gutmann,et al.  Optic pathway gliomas in neurofibromatosis‐1: Controversies and recommendations , 2007, Annals of neurology.

[60]  D. Louis.  WHO classification of tumours of the central nervous system , 2007 .

[61]  David N Louis,et al.  Molecular pathology of malignant gliomas. , 2006, Annual review of pathology.

[62]  S. Levy,et al.  Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[63]  R. Gibbs,et al.  SNPdetector: A Software Tool for Sensitive and Accurate SNP Detection , 2005, PLoS Comput. Biol..

[64]  M. Rosenblum,et al.  Monomorphous Angiocentric Glioma: A Distinctive Epileptogenic Neoplasm With Features of Infiltrating Astrocytoma and Ependymoma , 2005, Journal of neuropathology and experimental neurology.

[65]  D. Áfra,et al.  Supratentorial recurrences of gliomas. Morphological studies in relation to time intervals with astrocytomas , 2005, Acta Neurochirurgica.

[66]  Paola Pisani,et al.  Genetic Pathways to Glioblastoma , 2004, Cancer Research.

[67]  N. Probst-Hensch,et al.  Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas , 2004, Acta Neuropathologica.

[68]  I. Pollack.  The Role of Surgery in Pediatric Gliomas , 1999, Journal of Neuro-Oncology.

[69]  D. Áfra,et al.  Supratentorial recurrences of gliomas , 1978, Acta Neuropathologica.

[70]  D. Gutmann,et al.  Astrocyte-Specific Inactivation of the Neurofibromatosis 1 Gene (NF1) Is Insufficient for Astrocytoma Formation , 2002, Molecular and Cellular Biology.

[71]  P. Kleihues,et al.  Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[72]  A. Berns,et al.  Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer , 2001, Nature Genetics.

[73]  M. Ciesielski,et al.  Oncogenic epidermal growth factor receptor mutants with tandem duplication: gene structure and effects on receptor function , 2000, Oncogene.

[74]  J. Charrow,et al.  Intracranial gliomas in neurofibromatosis type 1. , 1999, American journal of medical genetics.

[75]  D Orlic,et al.  Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis. , 1999, Blood.

[76]  A. Kang,et al.  Characterization of signal transduction through the TCR-zeta chain following T cell stimulation with analogue peptides of type II collagen 260-267. , 1998, Journal of immunology.

[77]  J. Langston,et al.  Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[78]  Markus Voelter,et al.  State of the Art , 1997, Pediatric Research.

[79]  I. Pollack,et al.  Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases. , 1995, Journal of neurosurgery.

[80]  D. Lowy,et al.  Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis , 1992, Cell.

[81]  M E Cohen,et al.  Survival of children with brain tumors , 1986, Neurology.

[82]  M. Hojo,et al.  DIAGNOSTIC AND THERAPEUTIC IMPLICATIONS , 1978 .

[83]  H. S. Greene.  On the development of cancer. , 1948, Scientific American.